Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Higgs

Showing results (111-120 of 139) with videos related to

Pageof 14
Sort By:
International Journal of Obesity (2005)|September 15, 2015
Does low-energy sweetener consumption affect energy intake and body weight? A systematic review, including meta-analyses, of the evidence from human and animal studiesP J Rogers, P S Hogenkamp, C de Graaf, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|May 3, 2008
Guidance for contained field trials of vector mosquitoes engineered to contain a gene drive system: recommendations of a scientific working groupM Benedict, P D'Abbs, S Dobson, et al.
Journal of Health, Population, and Nutrition|July 5, 2014
Financial incentives and maternal health: where do we go from here?Lindsay Morgan, Mary Ellen Stanton, Elizabeth S Higgs, et al.
The Journal of Infectious Diseases|December 19, 2018
PREVAIL I Cluster Vaccination Study With rVSVΔG-ZEBOV-GP as Part of a Public Health Response in LiberiaFatorma K Bolay, Greg Grandits, H Clifford Lane, et al.
Vaccines|August 26, 2022
The Evolution of Medical Countermeasures for Ebola Virus Disease: Lessons Learned and Next StepsIan Crozier, Kyla A Britson, Daniel N Wolfe, et al.
The Lancet. Global Health|February 16, 2023
Clinical research as a critical component of epidemic response: the case of PREVAIL in LiberiaMosoka P Fallah, H Clifford Lane, Elizabeth S Higgs, et al.
Plos One|September 10, 2021
The impact of the 2014 Ebola epidemic on HIV disease burden and outcomes in Liberia West AfricaSoka J Moses, Ian Wachekwa, Collin Van Ryn, et al.
Journal of Clinical and Translational Science|October 31, 2024
Preparing better: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) therapeutics trials lessons learned: A call to the futureStacey J Adam, Timothy G Buchman, Judith S Currier, et al.
The Lancet. Global Health|August 22, 2025
National research ecosystems: protecting populations and building health security worldwideElizabeth S Higgs, Arshad Altaf, Nicole Lurie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2021
PREVAIL IV: A Randomized, Double-Blind, 2-Phase, Phase 2 Trial of Remdesivir vs Placebo for Reduction of Ebola Virus RNA in the Semen of Male SurvivorsElizabeth S Higgs, Dehkontee Gayedyu-Dennis, William A Fischer Ii, et al.
Pageof 14

Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
International Journal of Obesity (2005)|September 15, 2015
Does low-energy sweetener consumption affect energy intake and body weight? A systematic review, including meta-analyses, of the evidence from human and animal studiesP J Rogers, P S Hogenkamp, C de Graaf, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|May 3, 2008
Guidance for contained field trials of vector mosquitoes engineered to contain a gene drive system: recommendations of a scientific working groupM Benedict, P D'Abbs, S Dobson, et al.
Journal of Health, Population, and Nutrition|July 5, 2014
Financial incentives and maternal health: where do we go from here?Lindsay Morgan, Mary Ellen Stanton, Elizabeth S Higgs, et al.
The Journal of Infectious Diseases|December 19, 2018
PREVAIL I Cluster Vaccination Study With rVSVΔG-ZEBOV-GP as Part of a Public Health Response in LiberiaFatorma K Bolay, Greg Grandits, H Clifford Lane, et al.
Vaccines|August 26, 2022
The Evolution of Medical Countermeasures for Ebola Virus Disease: Lessons Learned and Next StepsIan Crozier, Kyla A Britson, Daniel N Wolfe, et al.
The Lancet. Global Health|February 16, 2023
Clinical research as a critical component of epidemic response: the case of PREVAIL in LiberiaMosoka P Fallah, H Clifford Lane, Elizabeth S Higgs, et al.
Plos One|September 10, 2021
The impact of the 2014 Ebola epidemic on HIV disease burden and outcomes in Liberia West AfricaSoka J Moses, Ian Wachekwa, Collin Van Ryn, et al.
Journal of Clinical and Translational Science|October 31, 2024
Preparing better: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) therapeutics trials lessons learned: A call to the futureStacey J Adam, Timothy G Buchman, Judith S Currier, et al.
The Lancet. Global Health|August 22, 2025
National research ecosystems: protecting populations and building health security worldwideElizabeth S Higgs, Arshad Altaf, Nicole Lurie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2021
PREVAIL IV: A Randomized, Double-Blind, 2-Phase, Phase 2 Trial of Remdesivir vs Placebo for Reduction of Ebola Virus RNA in the Semen of Male SurvivorsElizabeth S Higgs, Dehkontee Gayedyu-Dennis, William A Fischer Ii, et al.
Pageof 14